Abiopharma

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

New Form 6-K - Fresenius Medical Care AG Filed: 2025-08-11 AccNo: 0001104659-25-075917 Size: 55 KB

New Form 8-K - AGENUS INC Filed: 2025-08-11 AccNo: 0000950170-25-106235 Size: 319 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Karyopharm Therapeutics Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106236 Size: 487 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - MAIA Biotechnology, Inc. Filed: 2025-08-11 AccNo: 0001641172-25-022899 Size: 6 MB

New Form 10-Q - Apogee Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106234 Size: 10 MB

New Form 8-K - BioXcel Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001104659-25-075915 Size: 2 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Altimmune Board of Directors Appoints Jerry Durso as Chairman

New Form 424B4 - Longeveron Inc. Filed: 2025-08-11 AccNo: 0001213900-25-073922 Size: 353 KB

New Form 8-K - Charlie's Holdings, Inc. Filed: 2025-08-11 AccNo: 0001437749-25-025812 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 8-K - DuPont de Nemours, Inc. Filed: 2025-08-11 AccNo: 0001193125-25-177454 Size: 166 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Agenus Inc. - Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

New Form 10-Q - Immunovant, Inc. Filed: 2025-08-11 AccNo: 0001764013-25-000129 Size: 4 MB

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress